Aethlon Medical (AEMD) Gains from Investment Securities (2010 - 2026)
Aethlon Medical's (AEMD) quarterly Gains from Investment Securities came in at $284086.0 in Q1 2026, up 7.11% YoY from $265225.0 in Q1 2025, and up 22828.65% quarter-over-quarter from $1239.0 in Q4 2025.
Aethlon Medical (AEMD) Gains from Investment Securities (2010 - 2026) Analysis & Trends
Aethlon Medical's Gains from Investment Securities history runs 17 years deep, the most recent figure standing at $284086.0 for Q1 2026.
- For the quarter ending Q1 2026, Gains from Investment Securities rose 7.11% year-over-year to $284086.0; the trailing twelve-month figure through Mar 2026 stood at $294026.0 (up 9.28% YoY), and the FY2026 full-year result was $132109.0, up 86813.82% from the prior year.
- Gains from Investment Securities was $284086.0 for Q1 2026 at Aethlon Medical, up from $1239.0 in the prior quarter.
- Over the last five years, Gains from Investment Securities for AEMD reached as high as $284086.0 in Q1 2026 and fell as low as -$24406.0 in Q1 2024.
- Median Gains from Investment Securities over the past 5 years was $28651.0 (2023), compared with a mean of $90703.1.
- Across the five-year window, Gains from Investment Securities sank 199.99% in 2024 and jumped 1186.72% in 2025, its largest moves.
- Over 5 years, Gains from Investment Securities stood at $51370.0 in 2022, then plunged by 77.36% to $11628.0 in 2023, then soared by 1031.54% to $131576.0 in 2024, then slumped by 99.06% to $1239.0 in 2025, then soared by 22828.65% to $284086.0 in 2026.
- Business Quant data shows AEMD's Gains from Investment Securities at $284086.0 in Q1 2026, $1239.0 in Q4 2025, and $3344.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 154.42 Bn | 147.76 Bn | 6.27 Bn |
| 2 | Stryker | 118.12 Bn | 115.25 Bn | 3.81 Bn |
| 3 | Medtronic | 101.72 Bn | 93.55 Bn | 5.76 Bn |
| 4 | Boston Scientific | 67.19 Bn | 65.98 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 50.69 Bn | 47.02 Bn | 1.29 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn |
| 7 | Dexcom | 28.09 Bn | 26.97 Bn | 750.30 Mn |
| 8 | GE HealthCare Technologies | 28.08 Bn | 26.02 Bn | 1.98 Bn |
| 9 | Steris | 19.80 Bn | 19.37 Bn | 697.10 Mn |
| 10 | Aethlon Medical | 3.70 Mn | -1.32 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 284,086.00 |
| Mar 31, 2026 | 284,086.00 |
| Dec 31, 2025 | 1,239.00 |
| Dec 31, 2025 | 1,239.00 |
| Sep 30, 2025 | 3,344.00 |
| Sep 30, 2025 | 3,344.00 |
| Jun 30, 2025 | 5,357.00 |
| Jun 30, 2025 | 5,357.00 |
| Mar 31, 2025 | 265,225.00 |
| Mar 31, 2025 | 265,225.00 |
| Dec 31, 2024 | 131,576.00 |
| Dec 31, 2024 | 131,576.00 |
| Sep 30, 2024 | 3,832.00 |
| Sep 30, 2024 | 3,832.00 |
| Jun 30, 2024 | 32,894.00 |
| Jun 30, 2024 | 32,894.00 |
| Mar 31, 2024 | -24,406.00 |
| Mar 31, 2024 | -24,406.00 |
| Sep 30, 2023 | 11,628.00 |
| Sep 30, 2023 | 11,628.00 |